BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19649227)

  • 1. Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound.
    Shargal Y; Viola N; Nagler A; Merin G; Schmidt A; Buddecke E; Ben-Sasson SA; Vlodavsky I
    Exp Clin Cardiol; 2002; 7(2-3):73-9. PubMed ID: 19649227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
    Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
    Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound.
    Schmidt A; Vlodavsky I; Völker W; Buddecke E
    Atherosclerosis; 1999 Dec; 147(2):387-97. PubMed ID: 10559525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone.
    Nagler A; Miao HQ; Aingorn H; Pines M; Genina O; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):194-202. PubMed ID: 9012656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin glue containing fibroblast growth factor type 1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model.
    Zarge JI; Huang P; Husak V; Kim DU; Haudenschild CC; Nord RM; Greisler HP
    J Vasc Surg; 1997 May; 25(5):840-8; discussion 848-9. PubMed ID: 9152311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
    Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
    Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.
    Edelman ER; Nugent MA; Smith LT; Karnovsky MJ
    J Clin Invest; 1992 Feb; 89(2):465-73. PubMed ID: 1371124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor.
    Lindner V; Olson NE; Clowes AW; Reidy MA
    J Clin Invest; 1992 Nov; 90(5):2044-9. PubMed ID: 1430226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense strategies to inhibit restenosis.
    Lee M; Simon AD; Stein CA; Rabbani LE
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):487-92. PubMed ID: 10555157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Galphaq in smooth muscle cell proliferation.
    Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
    Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
    J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human basic fibroblast growth factor on restenosis after arterial endothelial injury in rats.
    Chang L; Zhang C; Wu YJ; Zhu RZ
    Acta Pharmacol Sin; 2001 Oct; 22(10):876-80. PubMed ID: 11749768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.
    Fukai N; Kenagy RD; Chen L; Gao L; Daum G; Clowes AW
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1356-62. PubMed ID: 19592464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia.
    Choi ET; Callow AD; Sehgal NL; Brown DM; Ryan US
    Arch Surg; 1995 Mar; 130(3):257-61. PubMed ID: 7887792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor.
    Rutherford C; Martin W; Salame M; Carrier M; Anggård E; Ferns G
    Atherosclerosis; 1997 Apr; 130(1-2):45-51. PubMed ID: 9126647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-Binding, N-Cadherin-Targeting Chimeric Peptide Inhibits Intimal Thickening but Not Endothelial Repair in Balloon-Injured Carotid Arteries.
    Burke-Kleinman J; Rubianto J; Hou G; Santerre JP; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1639-1652. PubMed ID: 37409527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
    Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in perlecan expression during vascular injury: role in the inhibition of smooth muscle cell proliferation in the late lesion.
    Kinsella MG; Tran PK; Weiser-Evans MC; Reidy M; Majack RA; Wight TN
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):608-14. PubMed ID: 12615671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.